---
title: "Mobia Medical, Inc. (MOBI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MOBI.US.md"
symbol: "MOBI.US"
name: "Mobia Medical, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-16T02:12:35.644Z"
locales:
  - [en](https://longbridge.com/en/quote/MOBI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MOBI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MOBI.US.md)
---

# Mobia Medical, Inc. (MOBI.US)

## Company Overview

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.mobia.com](https://www.mobia.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-15T04:30:13.000Z

**Overall: B (0.26)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 32 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 104.81% |  |
| Net Profit YoY | -88.99% |  |
| P/B Ratio | -2.64 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 398678961.55 |  |
| Revenue | 32040978.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 36.21% | A |
| Profit Margin | -145.12% | E |
| Gross Margin | 81.07% | A |
| Revenue YoY | 104.81% | A |
| Net Profit YoY | -88.99% | E |
| Total Assets YoY | 117.96% | A |
| Net Assets YoY | 229.92% | A |
| Cash Flow Margin | 98.27% | C |
| OCF YoY | 104.81% | A |
| Turnover | 0.91 | A |
| Gearing Ratio | 39.77% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Mobia Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "104.81%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-88.99%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-2.64",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "398678961.55",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "32040978.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "36.21%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-145.12%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "81.07%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "104.81%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-88.99%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "117.96%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "229.92%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "98.27%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "104.81%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.91",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "39.77%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -8.47 | 141/183 | - | - | - |
| PB | -2.61 | 159/183 | - | - | - |
| PS (TTM) | 12.29 | 118/183 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MOBI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MOBI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MOBI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MOBI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**